Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients
ClinicalTrials.gov study NCT01633099. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07392242. IPD Sharing: YES. Countries: 1. Publications: 0.
Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01662505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03224819. IPD Sharing: YES. Countries: 3. Publications: 0.
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03092674. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT02684162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03335267. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
ClinicalTrials.gov study NCT03701308. IPD Sharing: YES. Countries: 1. Publications: 0.
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00445744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02144675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04789408. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03730012. IPD Sharing: NO. Countries: 1. Publications: 0.
Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete
ClinicalTrials.gov study NCT03409081. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00233909. IPD Sharing: Not stated. Countries: 0. Publications: 1.
BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse
ClinicalTrials.gov study NCT01690624. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 Expression
ClinicalTrials.gov study NCT05512104. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00795002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00067028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00615784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06177067. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.